XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 3,000 $ 82,446,000 $ (65,610,000) $ 16,839,000
Balance (in Shares) at Dec. 31, 2022 3,247,930      
Common Stock issued to directors 54,000 54,000
Common Stock issued to directors (in Shares) 11,430      
Stock-Based Compensation 45,000 45,000
Net income (Loss) (618,000) (618,000)
Balance at Mar. 31, 2023 $ 3,000 82,545,000 (66,228,000) 16,320,000
Balance (in Shares) at Mar. 31, 2023 3,259,360      
Balance at Dec. 31, 2022 $ 3,000 82,446,000 (65,610,000) 16,839,000
Balance (in Shares) at Dec. 31, 2022 3,247,930      
Net income (Loss)       (1,013,000)
Balance at Jun. 30, 2023 $ 3,000 82,786,000 (66,623,000) 16,166,000
Balance (in Shares) at Jun. 30, 2023 3,274,590      
Balance at Mar. 31, 2023 $ 3,000 82,545,000 (66,228,000) 16,320,000
Balance (in Shares) at Mar. 31, 2023 3,259,360      
Common Stock issued to directors 54,000 54,000
Common Stock issued to directors (in Shares) 15,230      
Stock-Based Compensation 187,000 187,000
Net income (Loss) (395,000) (395,000)
Balance at Jun. 30, 2023 $ 3,000 82,786,000 (66,623,000) 16,166,000
Balance (in Shares) at Jun. 30, 2023 3,274,590      
Balance at Dec. 31, 2023 $ 3,000 82,928,000 (67,741,000) 15,190,000
Balance (in Shares) at Dec. 31, 2023 3,303,045      
Common Stock issued to directors 38,000 38,000
Common Stock issued to directors (in Shares) 12,323      
Stock-Based Compensation 24,000 24,000
Net income (Loss) (706,000) (706,000)
Balance at Mar. 31, 2024 $ 3,000 82,990,000 (68,447,000) 14,546,000
Balance (in Shares) at Mar. 31, 2024 3,315,368      
Balance at Dec. 31, 2023 $ 3,000 82,928,000 (67,741,000) 15,190,000
Balance (in Shares) at Dec. 31, 2023 3,303,045      
Exercise of Stock Options (in Shares) 1,475      
Net income (Loss)       (408,000)
Balance at Jun. 30, 2024 $ 3,000 83,040,000 (68,149,000) 14,894,000
Balance (in Shares) at Jun. 30, 2024 3,324,785      
Balance at Mar. 31, 2024 $ 3,000 82,990,000 (68,447,000) 14,546,000
Balance (in Shares) at Mar. 31, 2024 3,315,368      
Common Stock issued to directors 38,000 38,000
Common Stock issued to directors (in Shares) 7,942      
Exercise of Stock Options (in Shares) 1,475      
Stock-Based Compensation 12,000 12,000
Net income (Loss) 298,000 298,000
Balance at Jun. 30, 2024 $ 3,000 $ 83,040,000 $ (68,149,000) $ 14,894,000
Balance (in Shares) at Jun. 30, 2024 3,324,785